
¡¾Ô´´¡¿»ùÓÚBCS·ÖÀàµÄ»íÃâÏà¹ØÖ¸µ¼ÔÔòµÄ¶Ô±È
Ò»Ò»¡¢ BCSµÄ¶¨Òå
BCS£ºbiopharmaceutics classification sysetm£¬¹úÄÚÒ»°ãÒë×÷ÉúÎïÒ©¼Áѧ·ÖÀàϵͳ£¬ÊǸù¾ÝÒ©ÎïÔÚË®ÖеÄÈܽâ¶ÈºÍ³¦±ÚÉøÍ¸ÄÜÁ¦¶ÔÒ©Îï½øÐпÆÑ§·ÖÀàµÄ±ê×¼¡£¶ÔÓÚ¿Ú·þ¹ÌÌåËÙÊÍÖÆ¼Á¶øÑÔ£¬ÔÁÏÒ©µÄÈܽâÐÔ¡¢ÉøÍ¸ÐÔºÍÖÆ¼ÁµÄÈܳö¶ÈÕâ3 ¸ö·½Ãæ»ù±¾¾ö¶¨ÁËÒ©ÎïÔÚÌåÄÚµÄÎüÊÕËٶȺͳ̶ȡ£
¸ù¾ÝFDAÖ¸µ¼ÔÔòµÄ¶¨Ò壬ÔÁÏÒ©°´ÕÕBCS ¿É·ÖΪÒÔϼ¸Àࣺ
- BCS ¢ñ£º¸ßÈܽâÐÔ-¸ßÉøÍ¸ÐÔ£»
- BCS ¢ò£ºµÍÈܽâÐÔ-¸ßÉøÍ¸Àࣻ
- BCS ¢ó£º¸ßÈܽâÐÔ-µÍÉøÍ¸ÐÔ£»
- BCS ¢ô£ºµÍÈܽâÐÔ-µÍÉøÍ¸ÐÔ¡£
¶þ
¶þ ¡¢ ʲôÊÇ»ùÓÚBCSµÄÉúÎïµÈЧÐÔ»íÃâ
ÖÆ¼ÁÖ®¼äµÄÖÎÁƵÈЧÐÔÒ»°ãÐèÒª½øÐÐÌåÄÚÉúÎïµÈЧÐÔÑо¿À´ÂÛÖ¤£¬µ«ÊÇÈç¹ûÌåÍâÑо¿Äܹ»³ä·ÖÖ¤Ã÷ÌåÄÚÐÔÄÜÎÞ²îÒ죬ÄÇô¿ÉÒÔ»íÃâ´ËÏîÑо¿¡£¶ÔÓÚÌØ¶¨¼ÁÐÍ£¬ÔÚ·ûºÏijһ±ê׼ʱ£¬BCS ¿ÉÒÔ×÷ΪÉêÇëÈ˺ͼà¹Ü»ú¹¹ÆÀÅÐÊÇ·ñ¿ÉÒÔ»íÃâÉúÎïµÈЧÐÔÑо¿µÄ¹¤¾ß£¬
Õâ¾ÍÊÇ»ùÓÚBCS µÄÉúÎïµÈЧÐÔ»íÃâµÄ¶¨Òå¡£
Ŀǰ³ǫ̈µÄÏà¹ØÖ¸µ¼ÔÔòÈçÏ£º
WHO 2006Äê·¢²¼£ºTechnical Report Series No.937£¬ÆäÖÐAnnex 7ºÍAnnex 8ÒýÈë»ùÓÚBCSµÄÉúÎïµÈЧÐÔ»íÃâ¡£
EMEA 2010·¢²¼£ºNote for guidance on the Investigation on Bioavailability and Bioequivalence¡£
FDA 2017Äê12Ô·¢²¼£ºÉúÎïµÈЧÐÔBE»íÃâÖ¸µ¼ÔÔò£¬Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System Guidance for Industry¡£
ʳƷҩƷ¼à¶½¹ÜÀí¾Ö2016Äê5ÔÂ8ÈÕ·¢²¼£º2016ÄêµÚ87ºÅͨ¸æ¸½¼þ ÈËÌåÉúÎïµÈЧÐÔÊÔÑé»íÃâÖ¸µ¼ÔÔò¡£
CDE£ºICH¡¶M9£º»ùÓÚÉúÎïÒ©¼Áѧ·ÖÀàϵͳµÄÉúÎïµÈЧÐÔ»íÃâ¡·¡£CDEÔÚ2018Äê9ÔÂ5ÈÕÓë2020Äê05ÔÂ26ÈÕ¾ù·¢²¼ÁËÏà¹ØµÄÕ÷ÇóÒâ¼û¸å£¬²¢ÓÚ2021Äê12ÔÂ31ÈÕÕýʽ·¢²¼¹ØÓÚICH Q5D¡¢M9¼°M9ÎÊ´ðʵʩ½¨Ò鹫¿ªÕ÷ÇóÒâ¼ûµÄ֪ͨ£¬ÒªÇóÉêÇëÈËÐèÔÚÏÖÐм¼ÊõÒªÇó»ù´¡ÉÏ£¬¾¡Ôç°´ÕÕICHÖ¸µ¼ÔÔòµÄÒªÇó¿ªÕ¹Ñо¿£»±¾¹«¸æ·¢²¼Ö®ÈÕÆð6¸öÔºó¿ªÊ¼µÄÏà¹ØÑо¿£¨ÒÔÊÔÑé¼Ç¼ʱ¼äµãΪ׼£©£¬ÊÊÓÃÉÏÊöICHÖ¸µ¼ÔÔò¡£
ÒÔϽ«´ÓÕ⼸¸öÖ¸µ¼ÔÔò½øÐжԱȷÖÎö£º
Èý
Èý¡¢»íÃⷶΧ¡¢¼ÁÐÍÓ븨ÁÏÒªÇó
Ö¸µ¼ÔÔò |
»íÃⷶΧ |
¼ÁÐÍÒªÇó |
¸¨ÁÏÒªÇó |
FDA |
BCS IÀà |
ÊÊÓüÁÐÍΪ¿Ú·þ¹ÌÌåËÙÊÍÖÆ¼Á£¬²»°üÀ¨¿ÚÇ»ÄÚÎüÊյļÁÐÍ£¬È纬ƬºÍÉàÏÂÆ¬ |
ͨ³££¬Ê¹ÓþFDA Åú×¼µÄÓÃÓÚ¿Ú·þ¹ÌÌåËÙÊÍÖÆ¼ÁµÄ¸¨ÁÏ£¬²»»áÒýÆðBCS£¬ÀàÒ©ÎïµÄÎüÊÕÎÊÌâ¡£µ«ÊÇ£¬Èç¹û´¦·½ÖÐʹÓÃÁËи¨ÁÏ»òÕ߸¨ÁÏÓÃÁ¿³¬¹ý³£Á¿Ðí¶àʱ£¬Ó¦ÂÛÖ¤¸¨Áϲ»»áÓ°ÏìÒ©ÎïµÄÉúÎïÀûÓöȡ£Ä³Ð©¸¨ÁÏÓÃÁ¿½Ï´óʱ£¬Èç±íÃæ»îÐÔ¼Á( Èç¾ÛɽÀæõ¥-80) ºÍÌðζ¼Á(Èç¸Ê¶´¼¡¢É½Àæ´¼) £¬¿ÉÄÜ»áÒý·¢ÎÊÌ⣬ӦÓëÉóÆÀÈËÔ±¹µÍ¨ |
EMA |
BCS I¡¢IIIÀà |
ÊÊÓüÁÐÍΪ¿Ú·þ¹ÌÌåËÙÊÍÖÆ¼Á; ±ØÐëΪ·¢»ÓÈ«ÉíÖÎÁÆ×÷ÓõÄÖÆ¼Á; ¶ÔÓÚ¿ÚÇ»·ÖɢƬ»ò¿ÚÇ»±À½âƬ£¬Ó¦Åųý¿ÚÇ»ÎüÊÕ; ÊÊÓÃÓÚËÙÊÍÐ͸´·½ÖƼÁ£¬Ìõ¼þÊǸ´·½ÖеÄËùÓлîÐԳɷֶ¼ÊôÓÚBCS ·ÖÀà¢ñ»ò¢ó£¬²¢ÇÒ¸¨ÁÏ·ûºÏÕ½ÚIV£®2 µÄÒªÇó |
BCS ¢ñÔÁÏÒ©µÄÖÆ¼Á£¬½¨ÒéÊÔÑéÖÆ¼ÁʹÓÃÓë¶ÔÕÕÖÆ¼ÁÓÃÁ¿Ïà½üµÄÏàͬ¸¨ÁÏ BCS ¢óÔÁÏÒ©µÄÖÆ¼Á£¬ÎªÁËÅųý¶ÔĤתÔËÌåÓ°ÏìµÄ²»Í¬£¬Ó¦²ÉÓÃÓë¶ÔÕÕÖÆ¼Á¶¨ÐÔÏàͬ¶¨Á¿ÏàËÆµÄ¸¨ÁÏ¡£ ¶ÔÓÚ¿ÉÄÜÓ°Ïìµ½ÉúÎïÀûÓöȵĸ¨ÁÏ(ÈçɽÀæ´¼¡¢¸Ê¶´¼¡¢Ê®¶þÍé»ùÁòËáÄÆ»òÆäËû±íÃæ»îÐÔ¼Á) £¬Ó¦Á˽âÆä¶Ô賦È䶯¡¢ÓëÒ©ÎïµÄÏ໥×÷Óá¢ÉøÍ¸ÐÔ¡¢ÓëĤתÔËÌåÖ®¼äµÄÏ໥×÷Ó㬲¢ÔÚÊÔÑéÖÆ¼ÁºÍ¶ÔÕÕÖÆ¼ÁÖÐÓ¦¾ß¶¨ÐԺͶ¨Á¿µÄµÈͬÐÔ |
WHO |
BCS I¡¢II¡¢IIIÀà |
ÊÊÓüÁÐÍΪ¿Ú·þ¹ÌÌåËÙÊÍÖÆ¼Á; ¸´·½ÖƼÁ°´¡°×î²îÌõ¼þ¡±½øÐÐÊÔÑ飬ÀýÈ簢ĪÎ÷ÁֺͿËÀάËá¡£¿ËÀάËáÊôÓÚBCS ¢óÀ࣬°¢ÄªÎ÷ÁÖÊôÓÚBCS ¢ñÀ࣬ÄÇô¸´·½ÖƼÁ¾ÍÓ¦°´BCS ¢óÀàÒªÇó½øÐÐÊÔÑé |
ÔÚ¸¨ÁÏÖÖÀà·½Ãæ£¬·ÂÖÆÒ©¸¨ÁÏÓë¶ÔÕÕÒ©Ò»Ö£¬»òÕßÓëÒÑÔÚICH ³ÉÔ±¹úÉÏÊеÄͬƷÖÖ·ÂÖÆÒ©Ò»Ö¡£ÔÚ¸¨ÁÏÓÃÁ¿·½Ã棬·ÂÖÆÒ©¸¨ÁϺ¬Á¿Ó¦Óë¶ÔÕÕÒ©Ïà½ü£¬»òÕßÊǸÃÀà¼ÁÐ͵ij£¹æÓÃÁ¿ ¶ÔÓÚ·ûºÏ»íÃâÌõ¼þµÄº¬BCS ¢óÀà»îÐԳɷֵķÂÖÆÒ©£¬Ò»°ãÇé¿öÏ£¬µ±Ò©ÎïµÄÎüÊճ̶ȽϵÍ( ÌØ±ðÊǵ±Fabs £¼50%) ʱ£¬Èç¹ûÎüÊÕ²¿Î»¾ÖÏÞÓÚ賦µÀ½ü¶ËºÍ/»òÎüÊÕ¹ý³Ì·þ´ÓÓÕµ¼/¾ºÕù»úÖÆÊ±£¬ÐèÒª¶Ô¸¨Áϵ͍ÐԺͶ¨Á¿×é³É×÷ÏêϸÆÀ¹À£¨Æ«Àë¶ÔÕÕÒ©Ô½¶à£¬×÷³ö²»Êʵ±µÄ»íÃâ¾ö¶¨µÄ·çÏÕ¾ÍÔ½´ó£© ¶ÔÓÚ·ûºÏ»íÃâÌõ¼þµÄº¬BCS¢òÀà»îÐԳɷֵķÂÖÆÒ©£¬Ó¦¶Ô´¦·½ÖÐËùÓñíÃæ»îÐÔ¼ÁµÄÀàÐͺÍÓÃÁ¿½øÐÐÑϸñµÄÆÀ¹À |
ICH M9 |
BCS I¡¢IIIÀà |
ÊÊÓÃÓÚ½«Ò©ÎïÊäËÍÖÁÌåÑ»·µÄÆÕͨ¿Ú·þ¹ÌÌåËÙÊͼÁÐÍ»ò»ìÐü¼Á¡£¾ßÓÐÕÖÎÁÆ´°µÄÒ©ÎïÖÆ¼Á²»ÊÊÓñ¾Ö¸µ¼ÔÔòÖлùÓÚBCSµÄÉúÎïµÈЧÐÔ»íÃâ¡£¶ÔÓڹ̶¨¼ÁÁ¿¸´·½(FDC)ÖÆ¼Á£¬ÈôËùÓÐÒ©Îï»îÐԳɷݾù·ûºÏ±¾Ö¸µ¼ÔÔòµÚ2ºÍµÚ3Õ½ÚÖеıê×¼,ÔòÊÊÓûùÓÚBCSµÄÉúÎïµÈЧÐÔ»íÃâ¡£ |
ÀíÏëÇé¿öÏÂ,ÊÜÊÔÖÆ¼ÁµÄ×é³ÉӦģ·Â²Î±ÈÖÆ¼Á¡£µ«ÊÇ,Èô¸¨ÁÏ´æÔÚ²îÒ죬ӦÆÀ¼ÛÕâЩ²îÒì¿ÉÄܶÔÌåÄÚÎüÊÕ²úÉúµÄÓ°Ïì¡£ |
ËÄ¡¢ÌåÍâÑо¿µÄÒªÇó*
Îå¡¢¹ØÓÚ»ùÓÚBCS µÄÉúÎïµÈЧÐÔ»íÃâµÄÊÊÓñê×¼
1£©FDA
¢Ù ²»ÊôÓÚÖÎÁÆÖ¸ÊýÕµÄÒ©Îï¡£
¢Ú ÖÆ¼ÁΪ¿Ú·þ¹ÌÌåËÙÊÍÖÆ¼Á£¬²»°üÀ¨¿ÚÇ»ÄÚÎüÊÕµÄÒ©ÎÈ纬ƬºÍÉàÏÂÆ¬¡£
¢Û ÔÁÏÒ©ÊôÓÚBCS ¢ñÀà¡£
¢Ü ÖÆ¼ÁÄܹ»¿ìËÙÈܳö£¬¼´¸ÃÖÆ¼ÁÔÚ3 ÖÖ²»Í¬pH µÄÈܳö½éÖÊÖУ¨pH1.2£¬pH4.5ºÍpH6.8±ê×¼Èܳö½éÖÊ£©£¬ÒÔ½°·¨£¨50rpm£©»òÀº·¨£¨100rpm£©£¨Ìå»ý¡Ü900 mL£©£¬ÔÚ30min ÄÚµÄÈܳöÁ¿¡Ý85%¡£
¢Ý ¸¨ÁÏӦʹÓÃFDA Åú×¼µÄÓÃÓÚ¿Ú·þ¹ÌÌåËÙÊÍÖÆ¼ÁµÄ¸¨ÁÏ¡£È纬ÓÐи¨ÁÏ»òÔ¸¨ÁÏÓÃÁ¿³¬³£¶àʱ£¬Ó¦ÂÛÖ¤¸¨Áϲ»Ó°ÏìÒ©ÎïµÄÉúÎïÀûÓöȡ£Ä³Ð©¸¨ÁÏÓÃÁ¿¹ý´óʱ£¬Èç±íÃæ»îÐÔ¼Á£¨Èç¾ÛɽÀæõ¥-80£©ºÍÌðζ¼Á£¨Èç¸Ê¶´¼¡¢É½Àæ´¼£©¿ÉÄÜ»áÒý·¢ÎÊÌ⣬ÐèÓëÉóÆÀÈËÔ±¹µÍ¨¡£
2£©WHO
¢Ù ÖÆ¼ÁΪ¿Ú·þ¹ÌÌåËÙÊÍÖÆ¼Á¡£
¢Ú ÔÁÏÒ©¿ÉÒÔΪBCS¢ñ¡¢¢òºÍ¢óÀ࣬µ«¶ÔÓ¦µÄÖÆ¼ÁÈܳö¶ÈÒªÇó²»Í¬£»ÔÁÏҩΪBCS ¢ñÀà£ºÖÆ¼Á·ûºÏ¿ìËÙÈܳöµÄÒªÇ󣬼´ÔÚpH1.2£¬pH4.5ºÍpH6.8µÄ±ê×¼Èܳö½éÖÊÖУ¬ÒÔ½°·¨£¨75rpm£©»òÀº·¨£¨100rpm£©£¨Î¶È37¡æ£¬Ìå»ý¡Ü900 mL£©£¬ÔÚ30 min ÄÚµÄÈܳöÁ¿¡Ý85%¡£ÊÔÑéÖÆ¼ÁÓë¶ÔÕÕÖÆ¼ÁµÄÈܳöÇúÏ߱Ƚϣ¬f2>50¡£ÈôÊÔÑéÖÆ¼ÁÓë¶ÔÕÕÖÆ¼ÁÔÚÉÏÊöÈܳöÌõ¼þÏ£¬15 minÄÚµÄÈܳöÁ¿¡Ý85%£¬¿ÉÈÏΪÊǼ«¿ìËÙÈܳöÖÆ¼Á£¬²»ÔÙÐèÒª±È½ÏÈܳöÇúÏß¡£ÔÁÏҩΪBCS ¢óÀà: ÈôÊÔÑéÖÆ¼ÁÓë¶ÔÕÕÖÆ¼Á¶¼ÊǼ«¿ìËÙÈܳöµÄÖÆ¼Á£¬¼´ÔÚpH1.2£¬pH4.5ºÍpH6.8µÄ±ê×¼Èܳö½éÖÊÖУ¬ÒÔ½°·¨£¨75rpm£©»òÀº·¨£¨100rpm£©£¨Ìå»ý¡Ü900 mL£©£¬ÔÚ15 min ÄÚµÄÈܳöÁ¿¡Ý85%¡£ÕâÖÖÇé¿öÏ£¬¿ÉÒÔ¿¼ÂÇ»íÃâÉúÎïµÈЧÐÔÑо¿¡£Ò»°ãÇé¿öÏ£¬ÔÚ½øÐÐ×ÊÁÏÉóÆÀ£¨±ÈÈçÌØ¶¨²¿Î»ÎüÊÕ¡¢ÎüÊÕ²¿Î»µÄÒÖÖÆ/¾ºÕù¡¢¸¨ÁÏÒÔ¼°ÖÎÁÆ·çÏÕ£©Ê±£¬¶ÔBCS ¢óÀàÔÁÏÒ©µÄÖÆ¼Á×ö³ö»íÃâÉúÎïµÈЧÐÔÑо¿½áÂ۵ĴíÎó·çÏÕ¸ßÓÚBCS¢ñÀà¡£
ÔÁÏÒ©ÔÚpH6.8ÈÜÒºÖоßÓнϸßÈܽâÐÔµ«ÔÚpH1.2»òpH4.5ÈÜÒºÖÐÈܽâÐÔ²îµÄÖÆ¼Á( BCS¢òÖеÄÈõËáÐÔ»¯ºÏÎï) ¡£BCS ¢òÖÐÓÐһЩÈõËáÐÔ»¯ºÏÎïÔÁÏҩͬʱ·ûºÏÒÔÏÂÌõ¼þʱ£¬¿ÉÒÔ¿¼ÂÇ»íÃâÉúÎïµÈЧÐÔÑо¿£º
£¨i£©ÔÚpH6.8ÈÜÒºÖоßÓнϸßÈܽâÐÔ£¬¼´µ¥´Î¸øÒ©µÄ×î´ó¼ÁÁ¿ÄÜÈܽâÔÚ¡Ü250 mL pH6.8»º³åÒºÖС£
£¨ii£©ÖƼÁÓ¦·ûºÏpH6.8Ìõ¼þϵĿìËÙÈܳö£¬¼´ÔÚpH6.8µÄ±ê×¼Èܳö½éÖÊÖУ¬ÒÔ½°·¨£¨75rpm) »òÀº·¨(100 rpm) (Ìå»ý¡Ü900 mL) £¬ÔÚ30 min ÄÚµÄÈܳöÁ¿¡Ý85%¡£
£¨iii£©ÔÚpH1.2£¬pH4.5ºÍpH6.8µÄ±ê×¼Èܳö½éÖÊÏ£¬ÊÔÑéÖÆ¼ÁÓë¶ÔÕÕÖÆ¼ÁµÄÈܳöÇúÏ߱Ƚϣ¬f2£¾50¡£¶ÔÓÚ´ËÀà·ÂÖÆÒ©£¬Ó¦¶Ô´¦·½ÖÐËùÓõıíÃæ»îÐÔ¼Á¸¨ÁϵÄÀàÐͺÍÓÃÁ¿½øÐÐÑϸñµÄÆÀ¼Û¡£
¢Û ¸¨Áϲ»Ó¦µ¼ÖÂÊÔÑéÖÆ¼ÁÓë¶ÔÕÕÖÆ¼ÁÔÚÎüÊÕ·½ÃæµÄ²îÒ죨Èç¶Ô賦µÀÔ˶¯»òתÔ˹ý³ÌµÄÓ°Ï죩£¬Ò²²»Ó¦ÒòÏ໥×÷ÓöøÓ°Ïì»îÐÔÒ©ÎïµÄÒ©´ú¶¯Á¦Ñ§ÌØÐÔ¡£
3£©EMA
¢Ù È«ÉíÐÔ×÷ÓõĿڷþ¹ÌÌåËÙÊÍÖÆ¼Á£¬¶ÔÓÚ¿ÚÇ»·ÖɢƬ»ò¿ÚÇ»±À½âƬ£¬Ó¦Åųý¿ÚÇ»ÎüÊÕ¡£
¢Ú ÔÁÏÒ©²»Í¬BCS Àà±ð¼°ÖƼÁµÄÈܳö¶ÈÒªÇó£ºÔÁÏҩΪBCS ¢ñÀà: ÖÆ¼Á·ûºÏ¿ìËÙÈܳöµÄÒªÇ󣬼´ÔÚpH1.2¡¢pH4.5ºÍpH6.8µÄ±ê×¼Èܳö½éÖÊÖУ¬ÒÔ½°·¨£¨50rpm£©»òÀº·¨£¨100rpm£©£¨Ìå»ý¡Ü900 mL£©£¬ÔÚ30 min ÄÚµÄÈܳöÁ¿¡Ý85%¡£ÊÔÑéÖÆ¼ÁÓë¶ÔÕÕÖÆ¼ÁµÄÈܳöÇúÏ߱Ƚϣ¬f2>50¡£ÈôÊÔÑéÖÆ¼ÁÓë¶ÔÕÕÖÆ¼ÁÔÚÉÏÊöÈܳöÌõ¼þÏ£¬15 min ÄÚµÄÈܳöÁ¿¡Ý85%£¬¿ÉÈÏΪÊǼ«¿ìÁÏҩΪËÙÈܳöÖÆ¼Á£¬²»ÔÙÐèÒª±È½ÏÈܳöÇúÏß¡£BCS ¢óÀࣺÈôÊÔÑéÖÆ¼ÁÓë¶ÔÕÕÖÆ¼Á¶¼ÊǼ«¿ìËÙÈܳöµÄÖÆ¼Á£¬¼´ÔÚpH1.2¡¢pH4.5ºÍpH6.8µÄ±ê×¼Èܳö½éÖÊÖУ¬ÒÔ½°·¨£¨50rpm£©»òÀº·¨(100rpm£©£¨Ìå»ý¡Ü900 mL£©£¬ÔÚ15 min ÄÚµÄÈܳöÁ¿¡Ý85%¡£ÕâÖÖÇé¿öÏ£¬¿ÉÒÔ¿¼ÂÇ»íÃâÉúÎïµÈЧÐÔÑо¿¡£Ò»°ãÇé¿öÏ£¬Ó뺬BCS¢ñÀàµÄÖÆ¼ÁÏà±È£¬Ó¦¸üΪ½÷É÷µØÉó²éº¬BCS ¢óµÄÖÆ¼Á»íÃâÉúÎïµÈЧÐÔÑо¿µÄ·çÏÕ£¨±ÈÈçÌØ¶¨²¿Î»ÎüÊÕ¡¢ÓëÎüÊÕ²¿Î»×ªÔ˵°°×Ï໥×÷ÓõķçÏÕ¡¢¸¨ÁÏ×é³ÉÒÔ¼°ÖÎÁÆ·çÏÕ£©¡£
¢Û ¸¨ÁÏ£º¶ÔÓÚBCS¢ñºÍBCS ¢óÔÁÏÒ©£¬Ó¦Ê¹Ó󣹿ÓÃÁ¿µÄ³£Óø¨ÁÏ¡£¶ÔÓÚ¿ÉÄÜÓ°Ïìµ½ÉúÎïÀûÓöȵĸ¨ÁÏ£¨ÈçɽÀæ´¼¡¢¸Ê¶´¼¡¢Ê®¶þÍé»ùÁòËáÄÆ»òÆäËû±íÃæ»îÐÔ¼Á£© £¬Ó¦Á˽âÆä¶Ô賦È䶯¡¢ÓëÒ©ÎïµÄÏ໥×÷Óá¢ÉøÍ¸ÐÔ¡¢ÓëĤתÔËÌåÖ®¼äµÄÏ໥×÷Óã¬ÔÚÊÔÑéÖÆ¼ÁºÍ¶ÔÕÕÖÆ¼ÁÖÐÓ¦¾ß¶¨ÐÔÏàͬ¡¢¶¨Á¿ÏàËÆ¡£
¢Ü ¶ÔÓÚËÙÊ͸´·½ÖƼÁ£¬¸´·½ÖÐËùÓлîÐÔÒ©Îï³É·Ö¶¼Ó¦ÊôÓÚBCS¢ñ»òBCS ¢ó£¬²¢·ûºÏÏà¹ØÉÏÊöÌõ¼þ¡£
4£©ICH M9£ºÏê¼ûCDE¹ÙÍø·¢²¼µÄM9£º»ùÓÚÉúÎïÒ©¼Áѧ·ÖÀàϵͳµÄÉúÎïµÈЧÐÔ»íÃâ¡£
½áÓï
»ùÓÚBCSµÄÉúÎï»íÃâÑо¿²»Í¬µØÇøÓв»Í¬µÄÖ¸µ¼ÔÔò£¬¶øÔÚÖйúÏÖ½×¶ÎÖ´ÐеÄÊÇICH M9£º»ùÓÚÉúÎïÒ©¼Áѧ·ÖÀàϵͳµÄÉúÎïµÈЧÐÔ»íÃ⣬¿ÉÖØµã²Î¿¼Õâ¸öÖ¸µ¼ÔÔò½øÐÐÏà¹ØÑо¿¡£ÒÔÉÏÊDZÊÕßͨ¹ýÑо¿Ïà¹ØÖ¸µ¼ÔÔò×ܽá³öÀ´µÄÄÚÈÝ£¬Ï£Íû¶Ô¶ÁÕßÓаïÖú¡£